Tami Livnat

Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors—a single‐center cohort

Assaf Arie Barg, Einat Avishai, Ivan Budnik et al. · Pediatric Blood & Cancer · 2019 · 92 citations

Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies

Tami Livnat, Ilia Tamarin, Yoram Mor et al. · Thrombosis and Haemostasis · 2009 · 81 citations

Immunohematology, Severe Factor Xi, Immunology +19

Emicizumab treatment and monitoring in a paediatric cohort: real‐world data

Assaf Arie Barg, Tami Livnat, Ivan Budnik et al. · British Journal of Haematology · 2020 · 78 citations · Full text

Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring

Assaf A. Barg, Ivan Budnik, Einat Avishai et al. · Haemophilia · 2021 · 68 citations

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

U. Martinowitz, Tami Livnat, Ariela Zivelin et al. · Haemophilia · 2009 · 54 citations

Pharmacotherapy, Antimicrobial Chemotherapy, Sequential Therapy +20